MSB 2.23% $1.10 mesoblast limited

For those saying that Mesoblast is just clutching at straws...

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    For those saying that Mesoblast is just clutching at straws by saying the LVAD trial was a success despite not meeting the primary end point, just remember that medications like phosphodiesterase inhibitors (viagra) and minoxidil weren’t market beaters when it came to treating their primary end points of treating hypertension. What Mesoblast has proven through this recent trial is that their cells have anti inflammatory and immunomodulatory actions which have endless treatment applications over a ridiculous amount of medical conditions, especially with the significant increase in autoimmune diseases worldwide. 
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.